Study of California kidney cancer shows declining incidence, end of a trend

August 18, 2017

(SACRAMENTO, Calif.) -- A review of kidney cancer in California from 1988 through 2013 by the UC Davis Institute for Population Health Improvement (IPHI) has concluded that the high incidence of small tumors and early-stage disease observed in California from 1988 until about 2009 has declined and stabilized in recent years, signaling the end of a trend.

The research study, published online in the peer-reviewed journal Kidney Cancer, is important because it is the first report to demonstrate that the rising rate of kidney cancer seen in the U.S. over the past two decades may have ended. It also updates trends in kidney cancer incidence and mortality and documents the marked increase in the use of partial nephrectomies, a surgical treatment for early-stage disease that aims to preserve long-term kidney function.

"The increased incidence of small, localized tumors without a corresponding increase in kidney cancer deaths suggests that the incidence trends, until around 2009, were mostly driven by incidental findings associated with the increased use in advanced diagnostic imaging," said Cyllene Morris, lead author of the study and chief epidemiologist in IPHI's California Cancer Reporting and Epidemiologic Surveillance (CalCARES) Program.

Between 1996 and 2010, the authors observed that the use of ultrasound doubled, computed tomography (CT) tripled, magnetic resonance imaging (MRI) quadrupled and positron emission tomography (PET) scans increased tenfold after 2004. More specifically, CT scan use grew at an annual rate of 14.3 percent between 2000 through 2005 before dropping to a rate of increase of 7.1 percent in 2006 and then down to 1.4 percent in 2009.

"The greatest challenge in managing patients with small kidney tumors is distinguishing between aggressive tumors which require surgical treatment and less aggressive tumors that may be appropriately managed with active surveillance," said Kenneth W. Kizer, distinguished professor of emergency medicine and IPHI's director. "It's an important distinction because not all small renal tumors are indolent, and metastatic disease can be present at the time of diagnosis."

Kidney cancer is the eighth most commonly diagnosed cancer in California. In 2013, there were more than 5,600 new cases diagnosed and 1,350 deaths. The majority of these cancers are renal cell carcinomas (RCC), which are twice as likely to be diagnosed among males.

For the study, researchers used the California Cancer Registry to evaluate the records of 77,363 confirmed kidney cancer cases diagnosed in California from 1988 through 2013. The registry is a population-based cancer surveillance system that has collected statewide data on tumor characteristics, diagnosis, treatment, follow up and patient demographic information for cancers diagnosed since 1988. Data are collected through a network of regional registries, which are also affiliated with the National Cancer Institute's SEER program.

Their analysis of the trends showed that incidence of renal cell carcinoma (RCC) increase by about 1.5 percent per year from 1988 through 2000, rose steeply by about 4.8 percent per year until 2008, and then stabilized. During the study period, 91 percent of patients with localized RCC had surgery. The proportion of patients receiving a partial nephrectomy increased from 6.3 percent in 1988 to 56 percent in 2013, and when tumors larger than 4 cm were excluded, partial nephrectomies increased from 13.8 percent in 1988 to 74.6 percent in 2013.
The study is entitled "Kidney cancer incidence in California: End of the trend?" (DOI 10.3233/KCA-170005) Other authors on the paper include UC Davis Comprehensive Cancer Center medical oncologist and researcher Primo (Lucky) Lara Jr. and Arti Parikh-Patel, who is with the CalCARES program.

The collection of cancer incidence data was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by the California health and Safety Code, and the National Cancer Institute's Surveillance, Epidemiology and End Results program.

University of California - Davis Health System

Related Kidney Cancer Articles from Brightsurf:

Reducing urinary protein for patients with rare kidney disease slows kidney decline
New findings show that reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis can significantly slow declines in kidney function and extend time before patients' kidneys fail.

Acute kidney injury and end stage kidney disease in severe COVID-19
Many COVID-19 patients experience hematuria, proteinuria and elevated serum creatinine concentration early in the course of the disease.

Cutting off kidney cancer at its roots
Scientists at the MDC have discovered stem cells responsible for the most common form of kidney cancer.

Finding familiar pathways in kidney cancer
The famous cancer gene p53, which was thought to be less relevant in kidney cancer, may play a larger role than previously appreciated, suggesting new potential for treatment.

Root of childhood kidney cancer discovered
A fundamental change in our understanding of the childhood kidney cancer Wilms' tumor is on the horizon, after the discovery of its earliest genetic root by scientists at the Wellcome Sanger Institute and their collaborators.

Kidney-resident macrophages -- a role for healing during acute kidney injury?
Researchers have found that, during acute kidney injury in a mouse model, the kidney-resident macrophages are reprogrammed to a developmental state, resembling these same cells when they are found in newborn mice.

Antibodies to a retina protein to be used as a kidney cancer marker
Sechenov University together with their German colleagues suggest a new highly sensitive, quick, and pain-free method for diagnosing kidney cancer.

Revealed: 35 kidney genes linked to chronic kidney disease risk
An international study lead by University of Manchester scientists has discovered the identity of genes that predispose people to chronic kidney disease.

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have two, according to an analysis of the largest-ever, international dataset of solitary kidney patients to receive this emerging treatment.

Kidney cancer's developmental source revealed
In the first experiment of its kind, scientists have revealed the precise identity of cancer cells of the most common childhood and adult kidney cancers.

Read More: Kidney Cancer News and Kidney Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to